Cervical cancer screening in Taiwan:
This article was originally published in Clinica
Under Taiwan's national health insurance programme, women aged 30 and over are eligible for an annual Pap smear test. Entitlement drops to once every three years if the woman has a negative result for three consecutive years. Take-up rate for cervical cancer screening during the first year of the country's health insurance scheme was around 12.5%, Dr Yue-Chune Lee of the NHI Task Force revealed at the recent Pan-Asian Healthcare Summit in Singapore.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.